FDA Inspection 1169033 — Kearney, Susan L., M.D., Clinical Investigator

Kearney, Susan L., M.D., Clinical Investigator — FEI 3012808543

The FDA completed an inspection of Kearney, Susan L., M.D., Clinical Investigator on May 10, 2022 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review